Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

10x Genomics, Inc. Stock

Q: Can you buy 10x Genomics, Inc. stock?

You can no longer buy 10x Genomics, Inc.stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

10xgenomics.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $222.59MM

10x Genomics is a biotechnology company offering a range of products including software and hardware all aimed at better understanding biological systems.

Learn more about 10x Genomics, Inc. IPO

Enterprise Value

Access valuation and stock price for companies like 10x Genomics, Inc. before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

10x Genomics, Inc. stock FAQs

Can you buy 10x Genomics, Inc. stock?

You can no longer buy 10x Genomics, Inc. stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy 10x Genomics, Inc. stock?

To invest in a private company like 10x Genomics, Inc. through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell 10x Genomics, Inc. stock?

You can no longer sell stock of 10x Genomics, Inc. on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell 10x Genomics, Inc. stock?

If you hold private company shares of 10x Genomics, Inc. - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your 10x Genomics, Inc. stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is 10x Genomics, Inc. a public company?

No, 10x Genomics, Inc. is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is 10x Genomics, Inc.’s stock price?

The stock price of 10x Genomics, Inc. is $42.01 as of 1/18/24.

What is 10x Genomics, Inc.’s stock ticker symbol?

The ticker symbol of 10x Genomics, Inc. is TXG.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Serge Saxonov

Chief Executive Officer, Co-founder

Brad Crutchfield

Chief Commercial Officer

Ben Hindson

Chief Scientific Officer, President, Co-founder

Justin McAnear

Chief Financial Officer

Jean Philibert

Chief People Officer

Sam Ropp

Senior Vice President, Global Sales

Jonathan Schimmel

Vice President, Global Support and Sales Operations

Michael Schnall-Levin

Senior Vice President, R&D, Founding Scientist

Alexander Wong

Senior Vice President, Product, Software & Infrastructure

Paul Wyatt

Vice President, Operations

Eric Whitaker

General Counsel

Board Members

Serge Saxonov

Shehnaaz Suliman, M.D., M.Phil., M.B.A.

Sri Kosaraju

Penumbra

Mathai Mammen

Janssen

Bryan Roberts, Ph.D.

Venrock

John Stuelpnagel

Ben Hindson

FINSMES 09/10/2019

10x Genomics Prices Initial Public Offering | FinSMEs

10x Genomics, a Pleasonton, Calif.-based company that build products combining hardware, chemistry, and software to give single cell and spatial views of biological systems, priced its initial public offering

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.